HPTN Publications

Gorbach PM, Mensch BS, Husnik M, Coly A, Mâsse B, Makanani B, Nkhoma C, Chinula L, Tembo T, Mierzwa S, Reynolds K, Hurst S, Coletti A, Forsyth A . Effect of computer-assisted interviewing on self-reported sexual behavior data in a microbicide clinical trial. AIDS Behav. 2013, 17: 790-800
Goulder PJ, Tang Y, Brander C, Betts M, Altfeld M, Annamalai K, Trocha A, He S, Rosenberg E, Ogg G, O’Callaghan CA, Kalams SA, McKinney, Jr. RE, Mayer K, Koup RA, Pelton SI, Burchett SK, McIntosh K, Walker BD . Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med. 2000, 192: 1819-32
Grant RM, Mannheimer S, Hughes JP, Hirsch-Moverman Y, Loquere A, Chitwarakorn A, Curlin ME, Li M, Amico KR, Hendrix C, Anderson PL, Dye BJ, Piwowar-Manning E, McKinstry L, Elharrar V, Stirratt M, Rooney JF, Eshleman SH, Griensven F, Holtz T . A Randomized Open-Label Trial of Daily and Non-daily Oral Pre-exposure Prophylaxis in Men, and Transgender Women, Who Have Sex with Men: HPTN 067/ADAPT. Clin Infect Dis. 2018
Gregson S, Machekano R, Donnelly CA, Mbizvo MT, Anderson RM, Katzenstein DA . Estimating HIV incidence from age-specific prevalence data: comparison of concurrent cohort estimates in a study of male factory workers, Harare, Zimbabwe. AIDS. 1998, 12: 2049-58
Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, Wang L, Ou SS, Anderson M, McCauley M, Gamble T, Kumarasamy N, Hakim JG, Kumwenda J, Pilotto JH, Godbole SV, Chariyalertsak S, et.al, de Melo MG, Mayer KH, Eshleman SH, Piwowar-Manning E, Makhema J, Mills LA, Panchia R, Sanne I, Gallant J, Hoffman I, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Havlir D, Cohen MS, HPTN 052-ACTG Study Team . Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014, 14: 281-90 PMCID: 4144040
Gross M, Buchbinder SP, Celum C, Heagerty P, Seage GR, 3rd . Rectal microbicides for U.S. gay men. Are clinical trials needed? Are they feasible? HIVNET Vaccine Preparedness Study Protocol Team.. Sex Transm Dis. 1998, 25: 296-302
Gross M, Buchbinder SP, Holte S, Celum CL, Koblin BA, Douglas JM, Jr . Use of reality female condoms for anal sex by US men who have sex with men. HIVNET Vaccine Preparedness Study Protocol Team. Am J Public Health. 1999, 89: 1739-41
Gross M, Celum CL, Tabet SR, Kelly CW, Coletti AS, Chesney MA . Acceptability of a bioadhesive nonoxynol-9 gel delivered by an applicator as a rectal microbicide. Sex Transm Dis. 1999, 26: 572-578
Gross M, Holte S, Seage GR 3rd, Buchbinder SP, Metzger DS, Mayer KH . Feasibility of chemoprophylaxis studies in high risk HIV-seronegative populations. AIDS Educ Prev. 2000, 12: 71-8
Gross M, Holte SE, Marmor M, Mwatha A, Koblin BA, Mayer KH . Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team. J Acquir Immune Defic Syndr. 2000, 24: 393-8
Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, Emel L, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Dransfield K, Bray D, Mmiro F, Jackson JB . Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999, 354: 795-802
Guffey MB, Richardson B, Husnik M, Makanani B, Chilongozi D, Yu E, Ramjee G, Mgodi N, Gomez K, Hillier SL, Karim SA; HIV Prevention Trials Network (HPTN) 035 Study Team, Karim SA, HIV Prevention Trials Network (HPTN) 035 Study Team . HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women. Sex Transm Infect. 2014, 90: 363-9
Gupta A, Saple DG, Nadkarni G, Shah B, Vaidya S, Hingankar N, Chaturbhuj D, Deshmukh P, Walshe L, Hudelson SE, James M, Paranjape RS, Eshleman SH, Tripathy S . One-, two-, and three-class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India. AIDS Res Hum Retroviruses. 2010, 26: 25-31 PMCID: 2858895
Gwanzura L, McFarland W, Alexander, Burke RL, Katzenstein DA . Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe. J Infect Dis. 1998, 177: 481-4
Haley DF, Golin C, El-Sadr W, Hughes JP, Wang J, Roman Isler M, Mannheimer S, Kuo I, Lucas J, DiNenno E, Justman J, Frew PM, Emel L, Rompalo A, Polk S, Adimora AA, Rodriquez L, Soto-Torres L, Hodder S . Venue-based recruitment of women at elevated risk for HIV: an HIV Prevention Trials Network study. J Womens Health (Larchmt). 2014, 23: 541-51
Haley DF, Justman JE . The HIV epidemic among women in the United States: a persistent puzzle. J Womens Health. 2013, 22: 715-7
Haley DF, Lucas J, Golin CE, Wang J, Hughes JP, Emel LM, El-Sadr W, Frew PM, Justman J, Adimora AA, Watson CC, Mannheimer S, Rompalo A, Soto-Torres L, Tims-Cook Z, Carter Y, Hodder SL, HPTN 064 Study Team . Retention Strategies and Factors Associated with Missed Visits Among Low Income Women at Increased Risk of HIV Acquisition in the US (HPTN 064. AIDS Patient CARE STDS. 2014, 28: 206-17
Hall G, Li K, Wilton L, Wheeler D, Fogel J, Wang L, Koblin B, Fogel J . A Comparison of Referred Sexual Partners to Their Community Recruited Counterparts in The BROTHERS Project (HPTN 061). AIDS and Behavior. 2015, 19: 2214-23
Hall, G. C., Young, A., Krakauer, C., Watson, C. C., Cummings, V., Mayer, K., Koblin, B. . Sexual Risk Behaviors Among Black Men Who Have Sex With Men Who Also Report Having Sex With Transgender Partners: Analysis of HIV Prevention Trials Network (HPTN) 061 Study.. AIDS Educ Prev. 2017, 29: 418-431
Halperin DT, Weiss HA, Hayes R, Auvert B, Bailey RC, Caldwell J, Coates T, Padian N, Potts M, Ronald A, Short R, Williams B, Klausner J . Response to Ronald Gray, Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda ( 2000, 14:2371-2381). AIDS. 2002, 16: 810-2
Halpern SD, Metzger DS, Berlin JA, Ubel PA . Who will enroll? Predicting participation in a phase II AIDS vaccine trial. J Acquir Immune Defic Syndr. 2001, 27: 281-8
Hanrahan D, Sexton P, Hui K, Teitcher J, Sugarman J, London AJ, Barnes M, Purpura J, Klitzman R . Linguistic and Cultural Challenges in Communication and Translation in US-Sponsored HIV Prevention Research in Emerging Economies. PLoS One. 2015, 10: e01333394
Harawa N, Wilton L, Wang L, Mao C, Kuo I, Penniman T, Shoptaw S, Griffith S, Williams JK, Cummings V, Mayer K, Koblin B; HPTN 061 Study Team, Koblin B, HPTN 061 Study Team . Types of Female Partners Reported by Black Men Who Have Sex with Men and Women (MSMW) and Associations with Intercourse Frequency, Unprotected Sex and HIV and STI Prevalence. AIDS Behav. 2014, 18: 1548-59
Harrison LH, do Lago RF, Friedman, RK, Rodrigues L, Santos EM, de Melo MF, Moulton LH, Schechter, M . Incident HIV Infection in a high- risk, homosexual male cohort in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr. 1999, 21: 408-12
Hayes R, Ayles H, Beyers N, Sabapathy K, Floyd S, Shanaube K, Bock P, Griffith S, Moore A, Watson-Jones D, Fraser C, Vermund SH, Fidler S; HPTN 071 (PopART) Study Team, Fidler S, HPTN 071 (PopART) Study Team . HPTN 071 (PopART): Rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment – a study protocol for a cluster randomised trial. Trials. 2014, 15: 57 PMCID: 3929317
Hayes R, Fidler S, Cori A, Fraser C, Floyd S, Ayles H, Beyers N, El-Sadr W; HPTN 071 (PopART) Study Team, El-Sadr W, HPTN 071 (PopART) Study Team . HIV Treatment-As-Prevention Research: Taking the Right Road at the Crossroads. PLoS Med. 2015, 12
Hayes R, Floyd S, Schaap A, Shanaube K, Bock P, Sabapathy K, Griffith S, Donnell D, Piwowar-Manning E, El-Sadr W, Beyers N, Ayles H, Fidler S, HPTN 071 (PopART) Study Team . A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial. PLoS Med. 2017, 14: e1002292
Heimer R, Barbour R, Shaboltas AV, Hoffman IF, Kozlov AP . Spatial distribution of HIV prevalence and incidence among injection drugs users in St Petersburg: implications for HIV transmission. AIDS. 2008, 22: 123-30. PMCID:2778790
Hendriksen ES, Hlubinka D, Chariyalertsak S, Chingono A, Gray G, Mbwambo J, Richter L, Kulich M, Coates TJ . Keep Talking About It: HIV/AIDS-Related Communication and Prior HIV Testing in Tanzania, Zimbabwe, South Africa, and Thailand. AIDS Behav. 2009, 13: 1213-21 PMCID: 2866302
Hendrix CW, Andrade A, Bumpus NN, Kashuba AD, Marzinke MA, Moore A, Anderson PL, Bushman LR, Fuchs EJ, Wiggins I, Radebaugh C, Prince HA, Bakshi RP, Wang R, Richardson P, Shieh E, McKinstry L, Li X, Donnell D, Elharrar V, Mayer KH, Patterson KB . Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066). AIDS Res Hum Retroviruses. 2016, 32: 32-43
Hendrix CW, Cao YJ, Fuchs EJ . Topical microbicides to prevent HIV: clinical drug development challenges. Annu Rev Pharmacol Toxicol. 2009, 49: 349-75 PMID:19006450
Hickson, D. A., Mena, L. A., Wilton, L., Tieu, H. V., Koblin, B. A., Cummings, V., Latkin, C., Mayer, K. H. . Sexual Networks, Dyadic Characteristics, and HIV Acquisition and Transmission Behaviors Among Black Men Who Have Sex With Men in 6 US Cities. Am J Epidemiol. 2017, 185: 786-800
Hill, M. J., Holt, M., Hanscom, B., Wang, Z., Cardenas-Turanzas, M., Latkin, C. . Gender and race as correlates of high risk sex behaviors among injection drug users at risk for HIV enrolled in the HPTN 037 study. Drug Alcohol Depend. 2018, 183: 267-274
Hirschhorn L, Kunches L, Mayer K . Nonoccupational Postexposure Prophylaxis. Evolving Clinical Practice. AIDS Clinical Care. 2000, 12: 6-12
Hodder SL, Justman J, Haley DF, Adimora AA, Fogel CI, Golin CE, O'Leary A, Soto-Torres L, Wingood, G, El-Sadr WM Behalf of the HIV Prevention Trials Network, Domestic Prevention Working Group (HPTN DPWG) Women at Risk Group . Challenges of a Hidden Epidemic: HIV Prevention Among Women in the United States. JAIDS. 2010, 55: S69-S73 PMCID: 3551266
Hodder SL, Justman J, Hughes JP, Wang J, Haley DF, Adimora AA, Del Rio C, Golin CE, Kuo I, Rompalo A, Soto-Torres L, Mannheimer SB, Johnson-Lewis L, Eshleman SH, El-Sadr WM for HPTN 064, the Women's SeroIncidence Study Team . HIV Acquisition Among Women From Selected Areas of the
United States: A Cohort Study
. Ann Intern Med. 2013, 158: 10-18 PMCID: 4033695
Hofer CB, Harrison LH, Struchiner CJ, Moreira RI, do Lago RF, de Melo MF, Schechter M . Acute retrovirus syndrome among prospectively identified homosexual men with incident HIV infection in Brazil. The Projecto Praca Onze Study Group. Journal of Acquired Immune Deficiency Syndrome. J Acquir Immune Defic Syndr. 2000, 25: 188-91
Hoffman IF, Taha TE, Padian NS, Kelly CW, Welch JD, Martinson FE, Kumwenda NI, Rosenberg ZF, Chilongozi DA, Brown JM, Chirenje M, Richardson BA . Nonoxynol-9 100 mg gel: multi-site safety study from sub-Saharan Africa. AIDS. 2004, 18: 2191-5
Hsieh YH, Gaydos CA, Hogan MT, Jackman J, Jett-Goheen M, Uy OM, Rompalo AM . Perceptions on point-of-care tests for sexually transmitted infections – Comparison between frontline clinicians and professionals in industry. Point Care. 2012, 11: 126-9 PMCID: 3404836
Hsieh YH, Gaydos CA, Hogan MT, Uy OM, Jackman J, Jett-Goheen M, Albertie A, Dangerfield DT 2nd, Neustadt CR, Wiener ZS, Rompalo AM . What qualities are most important to making a point of care test desirable for clinicians and others offering sexually transmitted infection testing?. PLoS One. 2011, 6: e19263 PMCID: 3084795
Huang W, Eshleman SH, Toma J, Fransen S, Stawiski E, Paxinos EE, Whitcomb JM, Young AM, Donnell D, Mmiro F, Musoke P, Guay LA, Jackson JB, Parkin NT, Petropoulos CJ . Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. J Virol. 2007, 81: 7885-93 PMCID: 1951291
Huang W, Eshleman SH, Toma J, Stawiski E, Whitcomb JM, Jackson JB, Guay L, Musoke P, Parkin N, Petropoulos CJ . Vertical transmission of X4-tropic and dual-tropic HIV-1 in five Ugandan mother-infant pairs. AIDS. 2009, 23: 1903-8 PMCID: 2764460
Huang W, Toma J, Stawiski E, Fransen S, Wrin T, Parkin N, Whitcomb JM, Coakley E, Hecht FM, Deeks SG, Gandhi RT, Eshleman SH, Petropoulos CJ . Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individuals. AIDS Res Hum Retroviruses. 2009, 25: 795-802 PMCID: 2827835
Hudelson SE, Marlowe N, Huang W, Bruce R, Church JD, Husnik M, Donnell D, Coates T, Jackson JB, Chesney M, Koblin B Eshleman SH . Analysis of HIV type 1 gp41 and enfuvirtide susceptibility among men in the United States who were HIV infected prior to availability of HIV entry inhibitors. AIDS Res Hum Retroviruses. 2009, 25: 701-5 PMCID: 2746939
Hudelson SE, McConnell MS, Bagenda D, Piwowar-Manning E, Parsons TL, Nolan ML, Bakaki PM, Thigpen MC, Mubiru M, Fowler MG, Eshleman SH . Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration. AIDS. 2010, 24: 557-61 PMCID: 3065236
Hughes JP, Goldenberg R, Wilfert CM, Valentine M, Mwinga KG . Design of the HIV Prevention Trials Network (HPTN) Protocol 054: A cluster randomized crossover trial to evaluate combined access to nevirapine in developing countries. UW Biostatistics Working Paper Series. 2004, 195
Hughes JP, Haley DF, Golin CE, Adimora AA, Kuo I, Justman J, Soto-Torres L, Wang J, Hodder S . Regression to the mean and changes in risk behavior following study enrollment in a cohort of U.S. women at risk for HIV. 2015
Hughes JP, Richardson BA . Analysis of a randomized trial to prevent vertical transmission of HIV-1. JASA. 2000, 95: 1032-43
Hultin LE, Chow M, Jamieson BD, O'Gorman MRG, Menendez FA, Borowski L, Denny TN, and Margolick JB . Comparison of inter-laboratory variation in absolute T-cell counts by single-platform and optimized dual-platform methods. Cytometry Part B. 2010, 78: 194-200 PMCID: 3086643
Huppert JS, Hesse EA, Bernard MA, Xiao Y, Huang B, Gaydos CA, Kahn SA . Acceptability of self-testing for trichomoniasis increases with experience. Sex Transm Infect. 2011, 87: 494-500 PMCID: 3187610
Hussen SA, Stephenson R, Del Rio C, Wilton L, Wallace J, Wheeler D; HPTN 061 Protocol Team . HIV Testing Patterns among Black Men Who Have Sex with Men: A Qualitative Typology. PLoS One. 2013, 8: e75382 PMCID: 3777907
Incidence Assay Critical Path Working Group . More and better information to tackle HIV epidemics: towards improved HIV incidence assays. PLoS Med. 2011, 8: e1001045 PMCID: 3114871
Irvin R, Vallabhaneni S, Scott H, Williams JK, Wilton L, Li X, Buchbinder S; HPTN 061, Buchbinder S, HPTN 061 . Examining Levels of Risk Behaviors among Black Men Who Have Sex with Men (MSM) and the Association with HIV Acquisition. PLoS One. 2015, 10
Irvin R, Wilton L, Scott H, Beauchamp G, Wang L, Betancourt J, Lubensky M, Wallace J, Buchbinder S . A Study of Perceived Racial Discrimination in Black Men Who Have Sex with Men (MSM) and Its Association with Healthcare Utilization and HIV Testing. AIDS Behav. 2014, 18: 1272-8
Jackson B, Mmiro F, HIVNET 012 Study Team . HIVNET 012 and Petra (authors' reply). Lancet. 2004, 363: 244
Jackson JB, Barnett S, Piwowar-Manning E, Apuzzo L, Raines, C, Hendrix C, Hamzeh F, Gallant J . A Phase I/II study of nevirapine for pre-exposure prophylaxis of HIV-1 transmission in uninfected subjects at high risk. AIDS. 2003, 17: 547-53
Jackson JB, Becker-Pergola G, Guay LA, Musoke P, Mracna M, Fowler MG, Mofenson LM, Mirochnick M, Mmiro F, Eshleman SH . Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission. AIDS. 2000, 14: F111-5
Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Owor M, Ducar C, Deseyve M, Mwatha A, Emel L, Duefield C, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Gigliotti M, Bray D, Mmiro F . Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet. 2003, 362: 859-68
Jackson JB, Parsons T, Musoke P, Nakabiito C, Donnell D, Fleming T, Mirochnick M, Mofenson L, Fowler MG, Mmiro F, Guay L . Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission. AIDS. 2006, 20: 217-22 PMID: 16511414
Jackson JB, Wei L, Liping F, Aramrattana A, Celentano DD, Walshe L, Xing Y, Richardson P, Jun M, Beauchamp G, Donnell D, Ruan Y, Ma L, Metzger D, Shao Y . Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and Thailand. Hepat Res Treat. 2014, 2014: 296958
Jacob ST, Baeten JM, Hughes JP, Peinado J, Wang J, Sanchez J, Reid SE, Delany-Moretlwe S, Cowan F, Fuchs JD, Koblin B, Griffith S, Wald A, Celum C . A Post-Trial Assessment of Factors Influencing Study Drug
Adherence in a Randomized Biomedical HIV-1 Prevention Trial
. AIDS Behav. 2010, 15: 897-904 PMCID: 3076532
James MM, Laeyendecker O, Sun J, Hoover DR, Mullis CE, Cousins MM, Coates T, Moore RD, Kelen GD, Fowler MG, Kumwenda JJ, Mofenson LM, Kumwenda NI, Taha TE, Eshleman SH . Antibody maturation and viral diversification in HIV-infected women. PLoS One. 2013, 8: e57350 PMCID: 3583828
James MM, Wang L, Donnell D, Cousins MM, Barlow-Mosha L, Fogel JM, Towler WI, Agwu AL, Bagenda D, Mubiru M, Musoke P, Eshleman SH . Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children. Pediatr Infect Dis J. 2012, 31: e222-8 PMCID: 3473149
James MM, Wang L, Musoke P, Donnell D, Fogel J, Towler WI, Khaki L, Nakabiito C, Jackson JB, Eshleman SH . Association of HIV diversity and survival in HIV-infected Ugandan infants. PLoS One. 2011, 6: e18642 PMCID: 3077388
Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch MP . New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998, 280: 42-48
Jennings L, Pettifor A, Hamilton E, Ritchwood TD, Xavier Gomez-Olive F, MacPhail C, Hughes JP, Selin A, Kahn K, HPTN 068 Study Team . Economic Resources and HIV Preventive Behaviors Among School-Enrolled Young Women in Rural South Africa (HPTN 068). AIDS Behav.
Jennings L, Rompalo AM, Wang J, Hughes J, Adimora AA, Hodder S, Soto-Torres LE, Frew PM, Haley DF; HIV Prevention Trials Network (HPTN 064) Women’s HIV SeroIncidence Study (ISIS), Haley DF, HIV Prevention Trials Network (HPTN 064) Women’s HIV SeroIncidence Study (ISIS), HIV Prevention Trials Network (HPTN 064) Women’s HIV SeroIncidence Study . Prevalence and Correlates of Knowledge of Male Partner HIV Testing and Serostatus Among African-American Women Living in High Poverty, High HIV Prevalence Communities (HPTN 064). AIDS Behav. 2015, 19: 291-301
Joglekar N, Joshi S, Kakde M, Fang G, Cianciola M, Reynolds S, Mehendale S; HIV Prevention Trial Network 047 Protocol Team . Acceptability of PRO2000 vaginal gel among HIV un-infected women in Pune, India. AIDS Care. 2007, 19: 817-21 PMID: 17573603
John GC, Sheppard H, Mbori-Ngacha D, Nduati R, Maron D, Reiner M, Kreiss J . Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions. J Acquir Immune Defic Syndr. 2001, 26: 170-5
Jones D, Parkin N, Hudelson SE, Guay LA, Musoke P, Mmiro F, Jackson JB, Eshleman SH . Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine. AIDS Res Hum Retroviruses. 2005, 21: 319-24
Joshi S, Dutta S, Bell B, Profy A, Kuruc J, Fang G, Cianciola M, Maslankowski L, Soto-Torres L, Panchanadikar A, Mehendale S, Reynolds SJ . Documenting intermenstrual bleeding in a vaginal microbicide study: case reports and lessons learned. AIDS Res Hum Retroviruses. 2006, 22: 294-6
Julie Franks, Yael Hirsch-Moverman, Avelino S. Loquere Jr, K. Rivet Amico, Robert M. Grant, Bonnie J. Dye, Yan Rivera, Robert Gamboa, Sharon B. Mannheimer . Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study. AIDS and Behavior. 2017
Justman J, Befus M, Hughes J, Wang J, Golin CE, Adimora AA, Kuo I, Haley DF, Del Rio C, El-Sadr WM, Rompalo A, Mannheimer S, Soto-Torres L, Hodder S . Sexual Behaviors of US Women at Risk of HIV Acquisition: A Longitudinal Analysis of Findings from HPTN 064. AIDS Behavior. 2015, 19: 1327-37
Justman J, Goldberg A, Reed J, Bock N, Njeuhmeli E, Goldzier Thomas A . Adult male circumcision: reflections on successes and challenges. J Acquir Immune Defic Syndr. 2013, 63: S140-3
K Buchacz, J Farrior, G Beauchamp, L McKinstry, AE Kurth, BS Zingman, FM Gordin, D Donnell, KH Mayer, WM El-Sadr, B Branson . Changing Clinician Practices and Attitudes Regarding the Use of Antiretroviral Therapy for HIV Treatment and Prevention. 2017
K. Rivet Amico, Melissa Wallace, Linda-Gail Bekker, Surita Roux, Millicent Atujuna, Elaine Sebastian, Bonnie J. Dye, Vanessa Elharrar, Robert M. Grant . Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework. AIDS and Behavior.
Kafulafula G, Mwatha A, Chen YQ, Aboud S, Martinson F, Hoffman I, Fawzi W, Read JS, Valentine M, Mwinga K, Goldenberg R, Taha TE . Intrapartum antibiotic exposure and early neonatal, morbidity, and mortality in Africa. Pediatrics. 2009, 124: e137-44 PMCID: 2764263
Kajeepeta S, MacPhail C, Selin A, Gómez-Olivé FX, Gottert A, Kahn K, Hughes JP, Pettifor A . Gender attitudes and associations with sexual risk behaviors and outcomes among young South African women (HPTN 068).
Kaleebu P, Njai HF, Wang L, Jones N, Ssewanyana I, Richardson P, Kintu K, Emel L, Musoke P, Fowler MG, Ou SS, Jackson JB, Guay L, Andrew P, Baglyos L, Cao H; HPTN 027 protocol team . Immunogenicity of ALVAC-HIV vCP1521 in Infants of
HIV-1–Infected Women in Uganda (HPTN 027): The First
Pediatric HIV Vaccine Trial in Africa
. J Acquir Immune Defic Syndr. 2014, 65: 268-77
Kapiga S, Kelly C, Weiss S, Daley T, Peterson L, Leburg C, Ramjee G . Risk factors for incidence of sexually transmitted infections among women in South Africa, Tanzania, and Zambia: results from HPTN 055 study. Sex Transm Dis. 2009, 36: 199-206 PMID:19265734
Kapina M, Reid C, Roman K, Cyrus-Cameron E, Kwiecien A, Weiss S, Vermund SH . HIV Incidence Rates and Risk Factors for Urban Women in Zambia: Preparing for a Microbicide Clinical Trial. Sex Transm Dis. 2009, 36: 129-33 PMCID: 2889146
Karim QA, Baxter C, Karim SA . Topical microbicides--what's new?. J Acquir Immune Defic Syndr. 2013, 63: S144-9
Kashuba AD, Patterson KB, Dumond JB, Cohen MS . Pre-exposure prophylaxis for HIV prevention: how to predict success. Lancet. 2012, 379: 2409-11
Kawichai S, Celentano D, Srithanaviboonchai K, Wichajarn M, Pancharoen K, Chariyalertsak C, Visrutaratana S, Khumalo-Sakutukwa G, Sweat M, Chariyalertsak S; and The Project Accept Study Team . NIMH Project Accept (HPTN 043) HIV/AIDS Community Mobilization (CM) to Promote Mobile HIV Voluntary Counseling and Testing (MVCT) in Rural Communities in Northern Thailand: Modifications by Experience. AIDS Behav. 2012, 16: 1227-37 PMCID: 3355230
Kawichai S, Celentano DD, Chariyalertsak S, Visrutaratna S, Short O, Ruangyuttikarn C, Chariyalertsak C, Genberg B, Beyrer C . Community-based voluntary counseling and testing services in rural communities of Chiang Mai Province, Northern Thailand. AIDS Behav. 2007, 11: 770-7 PMID: 17503171
Keating SM, Bollinger RC, Quinn TC, Jackson JB, Carruth LM . Cross-clade T Lymphocyte Mediated Immunity to HIV-1: Implications for Vaccine Design and Immunodetection Assays. AIDS Res Hum Retroviruses. 2002, 18: 1067-79
Keating SM, Hanson D, Lebedeva M, Laeyendecker O, Ali-Napo NL, Owen SM, Stramer SL, Moore R, Norris PJ, Busch MP . Lower-sensitive and avidity modifications of the vitros anti-HIV1+2 assay for detection of recent HIV infections and incidence estimation. J Clin Microbiol. 2012, 50: 3968-76 PMCID: 3503010
Kevany S, Khumalo-Sakutukwa G, Murima O, Chingono A, Modiba P, Gray G, Van Rooyen H, Mrumbi K, Mbwambo J, Kawichai S, Chariyalertsak S, Chariyalertsak C, Paradza E, Mulawa M, Curran K, Fritz K, Morin SF . Health diplomacy the adaptation of global health interventions to local needs in sub-Saharan Africa and Thailand: evaluating findings from Project Accept (HPTN 043). BMC Public Health. 2012, 12: 459 PMCID: 3552975
Kevany S, Khumalo-Sakutukwa G, Singh B, Chingono A, Morin S, NIMH Project Accept Study Team . Global Health Diplomacy, Monitoring & Evaluation, and the Importance of Quality Assurance & Control: Findings from NIMH Project Accept (HPTN 043). PLoS One. 2016, 11: e0149335
Kevany S, Meintjes G, Rebe K, Maartens G, Cleary S . Clinical and financial burdens of secondary level care in a public sector antiretroviral roll-out setting (G. F. Jooste Hospital). S Afr Med J. 2009, 99: 320-5 PMID:19588792
Kevany S, Murima O, Singh B, Hlubinka D, Kulich M, Morin SF, Sweat M . Socio-economic status and health care utilization in rural Zimbabwe: findings from Project Accept (HPTN 043). J Public Health Africa. 2012, 3: 46-51 PMCID: 3436598
Kevany S, Sweat M, Singh B, Kulich M, Woelk G . Socio-economic status and health care utilization in rural Zimbabwe: Findings from Project Accept (HPTN 043). J of Public Health in Africa. 2012, 3: 46-51 (Not a PMC Journal)
Khoza MN, Delany-Moretlwe S, Scorgie F, Hove J, Selin A, Imrie J, et al. . Men’s perspectives on the impact of female-directed cash transfers on gender relations: Findings from the HPTN 068 qualitative study.. PLoS One. 2018, 13
Khumalo-Sakutukwa G, Morin SF, Fritz K, Charlebois ED, Van Rooyen H, Chingono A, Modilba P, Mrumbi K, Visrutaratna S, Singh B, Sweat M, Celentano DD, Coates TJ . Project Accept (HPTN 043): A Community-Based Intervention to Reduce HIV Incidence in Populations at Risk for HIV in Sub-Saharan Africa and Thailand. JAIDS. 2008, 49: 422-31 PMCID:2664736
Kilewo C, Natchu UCM, Young A, Donnell D, Brown E, Read JS, Sharma U, Chi BH, Goldenberg R, Hoffman I, Taha TE, Fawzi WW . Hypertension in Pregnancy among HIV-Infected Women in Sub-Saharan Africa: Prevalence and Infant Outcomes.. African Journal of Reproductive Health. 2009, 13: 25-36 PMID:20690271
Kilmarx PH, Paxton L, Van Damme L, Rees h, Ramjee G, Laga M, Mâsse B . Need for a true placebo for vaginal microbicide efficacy trials. Lancet. 2003, 361: 785-786